{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-087268","form_type":"8-K","ticker":"SENS","cik":"0001616543","company_name":"Senseonics Holdings, Inc.","filed_at":"2024-08-08T23:59:59+00:00","discovered_at":"2026-05-14T18:03:13.790421+00:00","generated_at":"2026-05-31T10:57:16.470570+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Q2 revenue $4.9M (+18% YoY), net loss $20.3M; 365-day Eversense Q4 launch on track","bullets":["Q2 2024 revenue $4.9M, up 18% vs $4.1M in Q2 2023; U.S. revenue $3.0M (+67%), OUS $1.9M.","Net loss $20.3M ($0.03/sh) vs $20.4M ($0.04/sh); gross profit slipped to $0.3M from $0.4M.","FY 2024 revenue guidance unchanged at $22M-$24M; cash burn expected ~$70M, in line with 2023.","FDA 510(k) review ongoing for 365-day Eversense; planned Q4 launch; Gemini System first-in-human testing began.","Eon Care Services subsidiary formed; Mercy collaboration RPM service initial insertions expected Q3 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-087268","json":"https://secwatch.observer/filing/0001104659-24-087268.json","markdown":"https://secwatch.observer/filing/0001104659-24-087268.md","text":"https://secwatch.observer/filing/0001104659-24-087268.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1616543/000110465924087268/0001104659-24-087268-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1616543/000110465924087268/tm2420870d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T10:57:16.470570+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}